Effect of Progressive Muscle Relaxation and Diaphragmatic Breathing on Sleep Disturbances in Chemotherapy Patients

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age40-60
SponsorCairo University

About this trial

This randomized controlled trial aims to investigate the effect of combined Progressive Muscle Relaxation (PMR) and Diaphragmatic Breathing (DB) techniques on sleep disturbances among patients receiving chemotherapy. Sleep disturbances are common among cancer patients undergoing chemotherapy and may negatively affect physical recovery, emotional well-being, and quality of life. Participants will be randomly assigned to either an intervention group receiving PMR and DB training in addition to routine care or a control group receiving routine care alone. Sleep outcomes will be assessed using the Pittsburgh Sleep Quality Index (PSQI), sleep diary records, and wearable sleep monitoring devices. The study seeks to determine whether the combined intervention can improve sleep quality and reduce sleep-related problems in chemotherapy patients.

Eligibility criteria

Qualifiers

• Aged between 40-60 years

Both male and female patients

Currently receiving at least the second cycle of chemotherapy

Receiving chemotherapy protocols (Zhou et al., 2022)

Disqualifiers

Diagnosed with sleep disorders unrelated to chemotherapy (e.g., obstructive sleep apnea)

Current use of sleep medications or anti-anxiety drugs

Diagnosed with major psychiatric conditions

Cognitive impairment limiting understanding of instructions

Trial design

Treatments tested in this trial

  • Progressive Muscle Relaxation and Diaphragmatic Breathing

Treatment groups

40 Participants
are divided into 2 treatment groups

Sponsors and collaborators